1-4 of 4
Bernhard Woermann, MD
Close
Sort by
Journal Articles

Moribund Blood Monocytes: Apoptosis Limits the Yield of Monocyte Derived Dentritic Cells from Apheresis Samples.

Lars Macke, Robert Geffers, Manfred Rohde, PhD, Henk S. Garritsen, MD, Bernhard Woermann, MD, Werner Lindenmaier, PhD, Kurt E. Dittmar, MD
Journal: Blood
Blood (2005) 106 (11): 3894.
https://doi.org/10.1182/blood.V106.11.3894.3894
Published: 2005
Journal Articles

Double Induction Containing Two Courses Versus One Course of High- Dose AraC/ Mitoxantrone (HAM) and Autologous Stem Cell Transplantation Versus Prolonged Maintenance for Acute Myeloid Leukemia (AML).

Thomas Buchner, MD, Wolfgang E. Berdel, MD, Claudia Schoch, MD, Torsten Haferlach, MD, Hubert L. Serve, MD, Joachim Kienast, MD, Susanne Schnittger, PhD, Wolfgang Kern, MD, Joelle Tchinda, PhD, Albrecht Reichle, MD, Peter Staib, MD, Wolf-Dieter Ludwig, MD, Carlo Aul, MD, Maria-Cristina Sauerland, Achim Heinecke, PhD, Bernhard Woermann, MD, Wolfgang Hiddemann, MD
Journal: Blood
Blood (2005) 106 (11): 272.
https://doi.org/10.1182/blood.V106.11.272.272
Published: 2005
Journal Articles

The Addition of Rituximab to Combination Chemotherapy with CHOP Has a Long Lasting Impact on Subsequent Treatment in Remission in Follicular Lymhoma but Not in Mantle Cell Lymphoma: Results of Two Prospective Randomized Studies of the German Low Grade Lymphoma Study Group (GLSG).

Wolfgang Hiddemann, MD, PhD, Roswitha Forstpointner, MD, Michael Kneba, MD, PhD, Norbert Schmitz, MD, PhD, Rudolf Schmits, MD, PhD, Bernd Metzner, MD, Marcel Reiser, MD, Eva Lengfelder, MD, PhD, Bernhard Woermann, MD, PhD, Hariett Harder, MD, Susanna Hegewisch-Becker, MD, PhD, Wolfgang Berdel, MD, PhD, Georg Hess, MD, Hartmut Eimermacher, MD, Ali Aldaoud, MD, Manfred Planker, MD, Reza Parwaresch, MD, PhD, Martin Dreyling, MD, PhD, Michael Unterhalt, MD
Journal: Blood
Blood (2004) 104 (11): 161.
https://doi.org/10.1182/blood.V104.11.161.161
Published: 2004
Journal Articles

Combined Immuno-Chemotherapy (R-CHOP) Results in Significantly Superior Response Rates and Time to Treatment Failure in First Line Treatment of Patients with Lymphomplasmocytoid/ic Immunocytoma (LP-IC) - Results of a Prospective Randomized Trial of the German Low Grade Lymphoma Study Group (GLSG).

Christian Buske, MD, PhD, Martin H. Dreyling, MD, PhD, Hartmut Eimermacher, MD, Hans-Peter Boeck, MD, Michael Pfreundschuh, MD, PhD, Bernd Metzner, MD, Roland Fuchs, MD, PhD, Bernhard Woermann, MD, PhD, Lorenz H. Truemper, MD, PhD, Georg Hess, MD, Hannes Wandt, MD, PhD, Wolf-Dieter Ludwig, MD, PhD, Ernst-Dietrich Kreuser, MD, PhD, Joerg Schimke, MD, H.-J. Weh, MD, PhD, Stephan Schmitz, MD, PhD, W. Schmiegel, MD, PhD, Michael Unterhalt, MD, Wolfgang Hiddemann, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 162.
https://doi.org/10.1182/blood.V104.11.162.162
Published: 2004